Esther Rajavelu
Stock Analyst at UBS
(0.74)
# 3,772
Out of 4,761 analysts
27
Total ratings
46.67%
Success rate
-22.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.53 | +277.36% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $20.73 | +54.37% | 2 | Apr 9, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $141 → $215 | $250.59 | -14.20% | 5 | Oct 4, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $42.59 | +71.40% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $36.91 | +195.31% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $8.33 | +320.17% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $32.32 | +16.03% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $136.01 | +67.63% | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $1.68 | - | 2 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $19.90 | - | 1 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $13 | $18.08 | -28.10% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.30 | +669.23% | 1 | Jul 21, 2017 |
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.53
Upside: +277.36%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $20.73
Upside: +54.37%
Alnylam Pharmaceuticals
Oct 4, 2021
Upgrades: Buy
Price Target: $141 → $215
Current: $250.59
Upside: -14.20%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $42.59
Upside: +71.40%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $36.91
Upside: +195.31%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $8.33
Upside: +320.17%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $32.32
Upside: +16.03%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $136.01
Upside: +67.63%
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $1.68
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $19.90
Upside: -
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $18.08
Upside: -28.10%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.30
Upside: +669.23%